Telo Genomics Corp.
TELO.V
TSX
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -1.68M | -1.87M | -1.93M | -1.94M | -1.87M |
| Total Depreciation and Amortization | 39.50K | 20.40K | 8.40K | 10.40K | 14.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 133.10K | 236.30K | 236.30K | 236.30K | 125.20K |
| Change in Net Operating Assets | 574.60K | 216.50K | 152.70K | 38.20K | 35.60K |
| Cash from Operations | -937.50K | -1.40M | -1.53M | -1.66M | -1.70M |
| Capital Expenditure | -13.50K | -15.80K | -3.80K | -2.30K | -4.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -147.90K | -147.90K | -- | -- | -- |
| Cash from Investing | -161.40K | -163.70K | -3.80K | -2.30K | -4.00K |
| Total Debt Issued | 1.25M | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | 0.00 |
| Issuance of Common Stock | 0.00 | 0.00 | 2.55M | 2.55M | 3.20M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 0.00 | -500.00 | -220.50K | -220.70K | -258.90K |
| Cash from Financing | 899.60K | -300.00 | 1.66M | 1.66M | 2.11M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -199.40K | -1.56M | 123.30K | 200.00 | 409.00K |